These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 24526250)

  • 1. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
    Younger J; Parkitny L; McLain D
    Clin Rheumatol; 2014 Apr; 33(4):451-9. PubMed ID: 24526250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
    Kim PS; Fishman MA
    Curr Pain Headache Rep; 2020 Aug; 24(10):64. PubMed ID: 32845365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.
    Trofimovitch D; Baumrucker SJ
    Am J Hosp Palliat Care; 2019 Oct; 36(10):907-912. PubMed ID: 30917675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose naltrexone's utility for non-cancer centralized pain conditions: a scoping review.
    Rupp A; Young E; Chadwick AL
    Pain Med; 2023 Nov; 24(11):1270-1281. PubMed ID: 37302106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
    Patten DK; Schultz BG; Berlau DJ
    Pharmacotherapy; 2018 Mar; 38(3):382-389. PubMed ID: 29377216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Featured Article: Serum [Met
    Ludwig MD; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2017 Sep; 242(15):1524-1533. PubMed ID: 28766982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.
    Oaks Z; Stage A; Middleton B; Faraone S; Johnson B
    Discov Med; 2018 Nov; 26(144):197-206. PubMed ID: 30695679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of naltrexone in the treatment of chronic pain: a systematic review.
    Rassi-Mariani V; Barreto ESR; Antunes CR; Alencar VB; Falcão Lins-Kusterer LE; Azi LMTA; Kraychete DC
    Pain Manag; 2024; 14(8):453-463. PubMed ID: 39301937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study.
    Martin SJ; McAnally HB; Okediji P; Rogosnitzky M
    Pain Manag; 2022 Sep; 12(6):699-709. PubMed ID: 35289682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.
    Toljan K; Vrooman B
    Med Sci (Basel); 2018 Sep; 6(4):. PubMed ID: 30248938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial.
    Bruun KD; Amris K; Vaegter HB; Blichfeldt-Eckhardt MR; Holsgaard-Larsen A; Christensen R; Toft P
    Trials; 2021 Nov; 22(1):804. PubMed ID: 34781989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial.
    Paula TMH; Castro MS; Medeiros LF; Paludo RH; Couto FF; Costa TRD; Fortes JP; Salbego MO; Behnck GS; Moura TAM; Tarouco ML; Caumo W; Souza A
    Braz J Anesthesiol; 2023; 73(4):409-417. PubMed ID: 35988815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low dose naltrexone for treatment of pain].
    Plesner KB; Vægter HB; Handberg G
    Ugeskr Laeger; 2015 Oct; 177(43):V03150248. PubMed ID: 26509454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells.
    Kučić N; Rački V; Šverko R; Vidović T; Grahovac I; Mršić-Pelčić J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series.
    McKenzie-Brown AM; Boorman DW; Ibanez KR; Agwu E; Singh V
    J Pain Res; 2023; 16():1993-1998. PubMed ID: 37337611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Low Dose Naltrexone for Chronic Pain.
    N Irwin M; A Cooke D; Berland D; D Marshall V; A Smith M
    J Pain Palliat Care Pharmacother; 2024 Mar; 38(1):13-19. PubMed ID: 38301136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent blockade of OGFr and treatment of autoimmune disorders.
    Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2018 Dec; 243(17-18):1323-1330. PubMed ID: 30541348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study).
    Colomer-Carbonell A; Sanabria-Mazo JP; Hernández-Negrín H; Borràs X; Suso-Ribera C; García-Palacios A; Muchart J; Munuera J; D'Amico F; Maes M; Younger JW; Feliu-Soler A; Rozadilla-Sacanell A; Luciano JV
    BMJ Open; 2022 Jan; 12(1):e055351. PubMed ID: 34992118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.